| INTRODUCTION
Seizures in dogs are sudden, short lasting and transient events that are characterized by motor, autonomic or behavioral features. 1 They are considered common events in dogs. 2 Causes including genetic and insult-triggered brain diseases, peripheral diseases, electrolyte imbalances, intoxications and idiopathic. 3 Seizure activity can have substantial impact on quality of life [3] [4] [5] as well as causing emotional distress for owners. 6, 7 To date, most studies have focused on the subset of cases that are classified as epileptic. 8, 9 Seizures are either epileptic or reactive according to the classification of the IVETF. Epileptic seizures are manifestations of excessive synchronous neuronal activity in the brain that is usually self-limiting and that are promoted by a predisposition of the brain for ictogenesis. 1, 10 Epilepsy is usually defined as requiring at least two unprovoked epileptic seizures more than 24 hours apart 11 and reactive seizures (also called provoked seizures) are considered as natural
Abbreviations: CI, confidence interval; EPR, electronic patient record; IQR, interquartile range; OR, odds ratio; PMS, practice management system; ROC, receiver operating characteristic; RVC, Royal Veterinary College; UK, United Kingdom; CNS, central nervous system; DYAR, dog years at risk; IVETF, International Veterinary Epilepsy Task Force responses from the normal brain to some transient disturbance in function (e.g. metabolic or toxic) which is reversible when the cause or disturbance is rectified. 1, 3 Analysis of a large pet insurance database reported an epilepsy incidence of 18 per 10,000 dog years at risk (DYAR) in Sweden for either idiopathic epilepsy or epileptic convulsions. 8 A study using primary-care veterinary clinical data reported a prevalence of 0.62% for epilepsy in dogs in the UK. 9 A cross sectional study compared period prevalence of epileptic seizures in a 2.5-year observation period between first opinion practices (0.43%) and a referral clinic in southern Germany (1.78%). 12 Among the referral subset of dogs seen at a veterinary teaching hospital in Germany, 2.6%
had a history of seizures reported. 13 Epidemiological studies using first opinion databases that explore seizures in general rather than relying on semi-arbitrary classification into various subsets might offer novel and more clinically pertinent insights into this disease in dogs. There are breed predispositions to various forms of epilepsy, but predisposition studies often fail to describe the prevalence of seizures either in dogs overall and in individual breeds.
This study aimed to identify and explore seizure occurrence in the general dog population under primary veterinary care in the UK. The specific objectives were to estimate the 1-year period prevalence for dogs that showed seizures and to also identify demographic risk factors associated with dogs that showed seizures, with breed as a risk factor of special interest. These results could be especially valuable for practitioners, insurance companies, pharmaceutical and nutrition manufacturers and pharmacovigilance agencies by providing a representative evidence-base that can be generalized to the wider dog population and fill the evidential data gap on seizure occurrence.
| MATERIALS AND METHODS
This study was based on data collected within the VetCompass™ Animal Surveillance System 14 at the Royal Veterinary College (RVC).
VetCompass™ collates electronic patient record (EPR) data from hundreds of UK primary-care practices for epidemiological research.
Demographic information collected included species, breed, date of birth, sex and neuter status, while clinical information includes free text notes, treatment data as well as summarized diagnosis terms from the VeNom Codes standardized lists. 15 Clinical data from participating practices are extracted from practice management systems (PMSs) using automated queries, uploaded securely to the RVC server and reformatted for entry into the VetCompass™ online database system.
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A cross-sectional analysis using cohort clinical data of dogs attending VetCompass™ practices was used to estimate the 1-year period prevalence and risk factors for dogs with at least one seizure during 2013. 17 The denominator population for the current study comprised all dogs that had at least one EPR (clinical note, bodyweight or treatment) recorded in VetCompass™ during 2013 or dogs that had 'at least one EPR before and one EPR after 2013'. These dogs were defined as being under veterinary care during 2013.
Sample size calculations estimated that a study with 149,698
dogs would be required to represent a disorder with 1% expected prevalence to a precision of 0.05% at a 95% confidence level from an estimated UK national population of 9.4 million dogs. 18, 19 A two-step letter-string search process was used to identify seizure cases in the VetCompass™ dog population. In step one, all EPRs were initially screened for candidate seizure cases using a range of letter-string search terms including seiz*, siez*, convul*, tonic*, clonic*, myoclo*, "had fit", "had a fit", epil*, diaz*, clonaz*, midazol*, phenobarb*, gabapen*, levetira*, bromide, pregaba*, zonis*, imepit*, pexi*, keppr*, hypnov*, epiph*, phenolep*, librom*, lyric*, alpraz* and zoneg*. In step two, the EPRs of all candidate cases which had been identified as possible seizure cases were manually read and evaluated for inclusion as a seizure case according to the study case definition.
A seizure case was defined as any dog with at least one seizure event occurring during 2013 recorded in the EPR. All dogs with reported seizure activity in 2013 were grouped as seizure cases and all remaining dogs were grouped as non-cases.
A "Purebred "variable classified all dogs of a recognizable breed as" purebred", all dogs recorded with a designer breed name as "designer" 20 and all remaining dogs as "crossbred" . A "Breeds" vari- and included all remaining dogs as "Breed not-Kennel Club recognized". The age for all dogs described the age at 31st December 2013.
An age variable "Age" contained 7 age categories in years (0.00 -≤ 0.50, 0.50 -≤ 3.00, 3.00 -≤ 6.00, 6.00 -≤ 9.00, 9.00 -≤ 12.00, ≥ 12.00, unrecorded) according to the IVETF guidelines. 21 The "Neuter affected with more complicated disease and more severe presentations and owned by more motivated owners. 23 Primary-care data collected and merged from many hundreds of clinics now offers study sample sizes of sufficiently large size to allow much greater numerical precision in results than has previously been possible. 23 It is estimated that 70% of UK dogs are registered with a veterinary practice and therefore results of studies using primary-care data offer good prospects of generalization to the wider dog population and clinical relevance of the emergent results to veterinarians.
19,24 The current study reported a 1-year prevalence of 0.82% for dogs affected by at least one seizure. To our knowledge, no previous studies have reported on the prevalence of seizures in the general dog population that can be used for direct comparison to this result. An earlier VetCompass™ study using primary-care data reported a prevalence of 0.62% for epilepsy of unknown origin in the UK. 9 This earlier study covered a longer period from January 2010 to April 2011 and focused specifically on the subset of dogs with "epilepsy of unknown origin", excluding any dogs which had a clinically identified underlying disease causing epilepsy, whereas the current study included all dogs with seizures from any etiology during a 1-year period. Thus, the previous reported prevalence is lower than the value reported in the current study as would be expected. Analysis of claim data from a large insurance database in Sweden reported a 0.75% prevalence of insured dogs with a recorded claim for epilepsy. 8 However, this prevalence among insured dogs might be higher than in the wider dog population under veterinary care because certain breed types perceived to have higher health risks may be preferentially insured. 25 Furthermore, the study dogs contributed an average of 4.2 years to the insurance study compared with the 1-year period included in the current study. Further studies have also reported on referral populations. 13, 26, 27 One of these studies reported a total seizure prevalence of 2.6% in a hospital population in Germany comprising 394 seizure case dogs admitted between January 2002 and March 2008. 13 This prevalence may exceed the 0.82% reported in the current UK primary-care study because primarycare caseloads include 24.2% of dogs that have no diseases recorded and many of the remaining have minor ailments. 23, 28 However, further factors that could partially account for the differences need to be considered and may include geographic and temporal differences between the studies as well as differing sample size and breed compositions. The proportional contribution of reactive seizures to the total seizure case burden has been variously estimated at between 13.6% and 32% respectively. 13, 26, 27 The differences between the study outcome might result from variation between study design (e.g. prospective versus retrospective analyses), countries, diagnostic procedures and animal population selection (e.g. primary-care versus referral caseloads). The results of the current study underline the relevance of undergraduate training and continuing education about the multiple causes of seizure events, the optimal diagnostic procedures, and the management options for seizure events in dogs. These period prevalence data should also be considered as a useful background presence of seizures when considering suspected adverse events reported to pharmacovigilance monitoring systems.
29,30
Risk factors results can provide valuable information to improve veterinary diagnosis of disease and hence to improve animal welfare monitoring. 31 The current study placed special focus on exploring breed as a risk factor for seizure occurrence because of prior evidence of genetic associations with epilepsy in dogs. 26 As might have been expected, seizures proved to be more frequent in purebreds compared to crossbred and designer dogs although the purebred predisposition could be heavily influenced by the subgroup of dogs with idiopathic epilepsy. In a recent longitudinal study at Copenhagen University Hospital, dogs with idiopathic epilepsy exhibited a breed distribution of 83.6% purebred and 16.4% crossbred. 26 However, hereditary factors might also contribute to structural epilepsy as well as non-epileptic seizures cases as the genetic background might, for instance, predispose to epilepsy development after a brain injury or might predispose to a peripheral disease associated with non-epileptic seizures.
Hybrid vigor (also known as heterosis or crossbred vigor) describes a phenomenon whereby the average performance of firstgeneration crosses for specified traits outperforms the average performance of their parental breeds 32 and has been proposed to enhance the health of crossbred compared with purebred animals for over 150 years. 33 Substantial evidence exists for these effects in production species of plants 34 and animals. [35] [36] [37] However, pet dogs are generally not kept for production traits and the strength of evidence to support the true impact of hybrid vigor in dogs has recently been questioned. 38 The findings in the current study that purebred dogs had 1.28 times higher odds of being seizure cases compared with crossbreds might add further weight to the existence of hybrid vigor in domestic dogs. Although the difference in effect shown might not appear to be substantial, it is likely that many of the crossbreds in our study were not first-generation crosses and therefore would have lost much of the additional health gains shown by first-generation crosses. 32 It is possible that any true reduction in seizure prevalence in crossbreds may have been much higher specifically in the firstgeneration subset of crosses but it was not possible to identify these dogs in the current study. The heterogeneity in genetics and health among the many individual breeds that exist among the purebred grouping should act as a further caveat to facile acceptance of the hybrid vigor concept. 28 Relative changes in the proportions of some common breeds that are either predisposed or protected to certain diseases could dramatically affect the overall probability of disease in purebred dogs overall. From this it is clear that resolving the hybrid vigor question in dogs has quite some way to go.
Exploration of associations, in both predisposition and protective directions, between individual breeds and the occurrence of seizures was of particular interest in this study. After accounting for other relevant factors, the final multivariable identified predisposition to seizures in 11 breeds with odds ratios ranging up to 3.41 times higher than that of Labrador Retrievers. Although the Labrador Retriever itself has previously been reported as a predisposed breed for epilepsy with a reported lifetime prevalence of 3.1%, 39 the current study elected to use the Labrador Retriever instead of crossbreds as the comparator breed in contrast to other previous studies 9 . Crossbred dogs, by definition, provide highly uncertain genetic structure, body conformation and parental-breed contribution compared with their purebred counterparts that are more standardized with higher genetic homozygosity, breed standards for conformation and defined parentage 40 The high count of Labrador Retrievers in the study also enabled high statistical power to explore breed risks. 41 However, interested readers who still wish to evaluate breed predisposition using crossbreds as the comparator category can still check for overlap of the 95% CI for each category; categories that do not overlap can be inter- The majority of previous studies in this area have focused on epilepsy in dog breeds and often went even further by specifically targeting the epilepsy subset with a suspected inheritance of idiopathic epilepsy. 10 Many of these earlier studies relied on relatively small groups of dogs or families that made it problematic to generalize the findings to the overall breed although recently some larger studies have reported breed-specific epilepsy prevalence estimates. 10 There are differing etiologies for epileptic seizures for Pugs (necrotizing encephalopathy) 42 and the Basset Hounds (Lafora disease). age into account and still showed an increased odds of seizures in neutered compared with entire bitches. This effect appears to be quite sex-specific however and no significant effect of neutering on seizure risk in males was noted. However, a word of caution in relation to the potential benefits of neutering in bitches: studies such as the current cross-sectional analysis can only show statistical association and must not be taken on their own as evidence of causality. 31, 54 It is also possible that these associations stem from reverse causality effects whereby bitches that show seizures might be more likely to be removed from the breeding pool and then neutered rather than the other way around. 52, 55 Future cohort analyses that follow animals over time to collect date information on the seizure onset and neutering as well as the rationale for the neutering decision are required to clarify the true role of neutering and seizure occurrence.
In agreement with previous studies, the current study identified increasing seizure risk with aging. 39, 52 It is also worth noting that our study design reported the age of all cases during 2013 rather than reporting the age that these animal first became a case. This means that the inference from the results describes the probability for seizure cases existing within these age groups (prevalence) rather than the probability of new cases developing during these ages (incidence).
However, a detailed investigation of seizure etiologies within the age groups was beyond the scope the study and would be required to further explore differing seizure etiologies across the age groups. A study of dogs referred for examination in Austria showed that idiopathic epilepsy was 3.25 times more likely to be the cause for seizure onset in dogs aged one to five years compared to structural epilepsy 56 whereas a US study of referred dogs identified that 65% of seizure cases older than five years were associated with structural epilepsy. 57 Dogs weighing over 40.00 kg in absolute bodyweight had significantly higher odds and dogs weighing between 30.00 -≤ 40.00 kg had a tendency to higher odds for seizures compared with dogs weighing under 10.00 kg. Although these findings might suggest increased seizure risk in larger dogs, it is also possible that these associations with bodyweight might result from seizure disease management using anti-convulsive treatment. Bodyweight gain due to polyphagia has been described as a common adverse effect of many antiepileptic drugs. 58 It is also worth noting that no effect was identified within breeds between dogs that weighed over or under their breed and sex average bodyweight.
In common with other epidemiological studies using primary-care veterinary clinical data, this study had some limitations. 16, 59 Retro- of focal seizures go unrecognized [60] [61] [62] and similar under-reporting of seizures has been considered in dogs. 63 Thus, the results of the present study might underestimate the true absolute period prevalence of seizures in the UK canine population but these effects are unlikely to affect the results of the risk factor analyses where similar underreporting is expected across all categories within each variable. 64 In conclusion, this analysis of over 450,000 dogs under primary veterinary care shows that the combined effects of epileptic and reactive seizures are a relatively common clinical finding with 0.82% of UK dogs affected in a 1-year period. As seizure diagnosis and management therefore constitute an important role in clinical practice, these results highlighting particular breeds, sex and aging as significant risk factors should assist veterinarian practitioners to identify and alert owners to dogs at higher risk. Enhanced owner awareness could promote earlier, faster and more reliable diagnosis and treatment to support improved animal welfare. These results can also assist pharmacovigilance efforts by providing baseline data from the overall population to optimize interpretability of seizures when reported as suspected adverse reaction to medication use. 
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